WO2012039350A1 - Skin cleanser composition - Google Patents
Skin cleanser composition Download PDFInfo
- Publication number
- WO2012039350A1 WO2012039350A1 PCT/JP2011/071189 JP2011071189W WO2012039350A1 WO 2012039350 A1 WO2012039350 A1 WO 2012039350A1 JP 2011071189 W JP2011071189 W JP 2011071189W WO 2012039350 A1 WO2012039350 A1 WO 2012039350A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mass
- polyoxyethylene
- liquid crystal
- acid
- skin cleanser
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0295—Liquid crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Definitions
- the semi-solid detergent composition can keep particles such as scrubs dispersed in the preparation, and can improve the appearance and feel.
- a gel-like cleaning agent having a transparent to translucent appearance can provide consumers with a high quality feeling.
- Patent Document 2 JP-A-2007-511168. Publication). This is not a thickening due to the polymer compound but gelation by the liquid crystal phase of the surfactant, so stringing during use is difficult to occur, but it is difficult to remove from the container due to its high viscosity, and water was added. In some cases, the preparation is difficult to extend and falls from the hand.
- a skin cleanser composition containing the following components (A), (B), (C) and (D) and in a liquid crystal state at 25 ° C. (A) 15 to 45% by mass of higher fatty acid salt having 8 to 26 carbon atoms (B) Betaine amphoteric surfactant 7 to 25% by mass (C) 1 to 5% by mass of the following nonionic surfactant Three hydroxyl groups of polyoxyethylene (average added mole number of ethylene oxide 10 to 80) glyceryl, glycerin, or polyoxyethylene (average added mole number of ethylene oxide 10 to 80) trimethylolpropane are esterified or etherified.
- liquid-form skin cleanser composition that has excellent stability during storage at high and low temperatures and has good usability even when the hand is wet.
- the skin cleanser composition of the present invention is a skin cleanser composition containing the following components (A), (B), (C) and (D) and being in a liquid crystal state at 25 ° C. .
- (C) 1 to 5% by mass of the following nonionic surfactant Three hydroxyl groups of polyoxyethylene (average added mole number of ethylene oxide 10 to 80) glyceryl, glycerin, or polyoxyethylene (average added mole number of ethylene oxide 10 to 80) trimethylolpropane are esterified or etherified.
- the esterified or etherified moiety is a saturated or unsaturated, linear or branched monovalent hydrocarbon group having 7 to 25 carbon atoms, and part of the hydrogen atoms are substituted with hydroxyl groups.
- the polyoxyethylene having an average addition mole number of 10 to 80 may be added to this hydroxyl group, provided that the total number of polyoxyethylene added to the nonionic surfactant is the average addition mole number. 10 to 80. (D) 15 to 35% by mass of polyhydric alcohol
- the (A) higher fatty acid salt of the present invention is a higher fatty acid salt having 8 to 26 carbon atoms, and the monovalent hydrocarbon group moiety is either linear or branched, saturated or unsaturated. It may be used alone or in combination of two or more. Among these, higher fatty acid salts represented by the following general formula (1) are preferable.
- R 1 COOM (1) (In the formula, R 1 represents a linear or branched, saturated or unsaturated monovalent hydrocarbon group having 7 to 25 carbon atoms, and part or all of the hydrogen atoms of the monovalent hydrocarbon group are hydroxyl groups. (M may be potassium, sodium, monoethanolamine, diethanolamine, triethanolamine, 2-amino-2-methyl-1-propanol or diisopropanolamine.)
- Component (A) includes caproic acid, heptanoic acid, caprylic acid, pelargonic acid, capric acid, undecanoic acid, lauric acid, caproleic acid, undecylenic acid, lauroleic acid, 2-ethylbutanoic acid, isopentanoic acid, 2-ethylpentanoic acid 2-ethylhexanoic acid, isononanoic acid, 3,5,5-trimethylhexanoic acid, tridecanoic acid, tetramethylnonanoic acid, myristic acid, pentadecanoic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, lignoceric acid, cellotine Acid, myristoleic acid, palmitoleic acid, oleic acid, elaidic acid, gondoic acid, erucic acid, cerakoleic acid, linoleic acid, linoelai
- component (A) is 15 to 45% by mass in the skin cleanser composition. If it is less than 15% by mass, no liquid crystal is formed. On the other hand, when it exceeds 45 mass%, a precipitate is produced at a low temperature. Further, from the viewpoint of foaming and low-temperature stability, 17 to 40% by mass, particularly 20 to 35% by mass, and particularly 25 to 35% by mass are preferable.
- Betaine-type amphoteric surfactant examples include imidazoline type (amidoamine type), carbobetaine type, sulfobetaine type, and phosphobetaine type. These can be used individually by 1 type or in combination of 2 or more types. Among these, the carbobetaine type is preferable in that it easily forms liquid crystals.
- the amphoteric surfactant may contain sodium chloride in the production process, and is desalted from the viewpoint of improving low-temperature stability, so that sodium chloride is reduced to 1% by mass or less in the amphoteric surfactant aqueous solution. Is more preferable.
- component (B) is 7 to 25% by mass, preferably 9 to 15% by mass, in the skin cleanser composition. If it is less than 7% by mass, no liquid crystal is formed, and if it exceeds 25% by mass, precipitation tends to occur at a low temperature.
- the component (C) of the present invention contains polyoxyethylene (average added mole number of ethylene oxide 10 to 80) glyceryl, glycerin, or polyoxyethylene (average added mole number of ethylene oxide) 10 to 80) A compound in which three hydroxyl groups of trimethylolpropane are esterified or etherified, and the esterified or etherified moiety is a saturated or unsaturated, linear or branched chain having 7 to 25 carbon atoms.
- the solubility of the preparation in water decreases.
- the total number of polyoxyethylenes added to the nonionic surfactant is more preferably 15 to 40 mol. If the amount is less than 10 moles, the solubility of the preparation in water and the low-temperature stability may decrease, and the cloudiness may result in loss of transparency. If the amount exceeds 80 moles, the high-temperature stability is deteriorated.
- nonionic surfactants (i) to (iii) having the following structures are excellent in stability during storage at high temperatures and low temperatures, and have good usability even when the hands are wet. It is preferable because a cleaning composition can be obtained.
- nonionic surfactant examples include PEG-20 glyceryl triisostearate, PEG-20 glyceryl tristearate, PEG-20 glyceryl trioleate, and the like.
- (Ii) A compound in which three hydroxyl groups of glycerin are esterified or etherified, and the esterified or etherified moiety is a saturated or unsaturated, linear or branched monovalent carbonization having 7 to 25 carbon atoms.
- Nonionic surfactant in which a part of hydrogen atom is substituted with a hydroxyl group, and polyoxyethylene having an average addition mole number of 10 to 80 is added to this hydroxyl group (however, nonionic surfactant The total number of polyoxyethylenes added to is an average addition mole number of 10 to 80).
- Nonionic surfactant to which oxyethylene may be added (however, the total number of polyoxyethylene added to the nonionic surfactant is 10 to 80 in terms of the average number of moles added)
- nonionic surfactant examples include PEG-20 trimethylolpropane triisostearate.
- the esterified or etherified moiety is a monovalent hydrocarbon group having 7 to 25 carbon atoms, preferably 16 to 20 carbon atoms, and the monovalent hydrocarbon group may be saturated or unsaturated, linear or branched, A part of hydrogen atoms may be substituted with a hydroxyl group.
- a branched hydrocarbon chain or a hydrocarbon chain having a hydroxyl group at a portion other than the terminal of the hydrocarbon chain is more preferable.
- the nonionic surfactant corresponding to said (ii) is more preferable at the point of the solubility of a formulation to water, and polyoxyethylene hydrogenated castor oil and polyoxyethylene castor oil are more preferable.
- the esterified fatty acid residue portion of polyoxyethylene castor oil (the portion combining the hydrocarbon chain and the ester group) is an unsaturated fatty acid (87% by mass of ricinoleic acid, 7% by mass of oleic acid, and linoleic acid 3 mass%) and a small amount of saturated fatty acid (palmitic acid, stearic acid 3 mass%).
- the fatty acid is hydrogenated.
- the fatty acid distribution of the fatty acid residue contains 80% by mass or more of ricinoleic acid having a hydroxyl group at position 12 or a hydrogenated product thereof.
- polyoxyethylene hydrogenated castor oil (EO.20) [POE (20) hydrogenated castor oil], polyoxyethylene hydrogenated castor oil (E.O.40) [POE (40) hydrogenated castor oil], polyoxy Ethylene castor oil (E.O.20) [POE (20) castor oil], POE (40) castor oil [POE (40) castor oil] have excellent stability during high-temperature and low-temperature storage and wet hands It is most preferable from the viewpoint that a liquid skin cleansing composition having good usability even in a state can be obtained.
- the mechanism is unknown, but POE hydrogenated castor oil and POE castor oil are considered to have loosened the liquid crystal structure because of the structure in which the polyoxyethylene chain is branched from the hydroxyl group present in the hydrocarbon group.
- component (C) is 1 to 5% by mass, particularly 2 to 4% by mass, and particularly preferably 2 to 3% by mass in the skin cleanser composition. If it is less than 1% by mass, the preparation is not sufficiently soluble in water, and if it exceeds 5% by mass, the high-temperature stability is deteriorated.
- the polyhydric alcohol is preferably a dihydric to hexahydric one, such as ethylene glycol, diethylene glycol, polyethylene glycol 200 (a quasi-drug raw material standard 2006 equivalent), polyethylene glycol 300 (a quasi-drug raw material).
- polyethylene glycol 400 (quasi-drug raw material standard 2006 equivalent), polyethylene glycol 600 (quasi-drug raw material standard 2006 equivalent), propylene glycol, dipropylene glycol, 1,3-butylene glycol, Isopentyldiol, pentylene glycol, 1,2-hexanediol, hexylene glycol, glycerin, diglycerin, sorbit, xylitol, mannitol and the like are preferable, and these are used alone or in appropriate combination of two or more. Can be used.
- polyethylene glycol corresponds to those defined in Cosmetic Material Standard 2nd Edition Comment, Quasi-drug Raw Material Standard 2006, Japanese Pharmacopoeia Pharmaceutical Standard 2002, 15th revised Japanese Pharmacopoeia.
- propylene glycol, polyethylene glycol 200, polyethylene glycol 300, polyethylene glycol 400, polyethylene glycol 600, propylene glycol, glycerin, and sorbit are preferable from the viewpoint of easy formation of liquid crystals.
- a mixture of divalent and trivalent polyhydric alcohols is more preferable, a combination of propylene glycol and glycerin is more preferable, and the mass (%) of propylene glycol / glycerin The mass (%) is particularly preferably 20/80 to 50/50.
- the ratio of propylene glycol exceeds 50/50, the liquid crystal formability may be lowered and high-temperature stability may be lowered, and when it is less than 20/80, the viscosity may be too high.
- the mass ratio of (A) higher fatty acid salt and (B) betaine-type amphoteric surfactant is preferably 85/15 to 60/40.
- the ratio of the component (A) exceeds 85/15, the stability at low temperatures may be deteriorated, and when it is less than 60/40, it may cause luster during rinsing.
- the mass ratio of (A) higher fatty acid salt and (D) polyhydric alcohol is preferably 70/30 to 40/60.
- the ratio of the component (A) exceeds 70/30, the low temperature stability may be deteriorated, and when it is less than 40/60, the high temperature stability and transparency may be deteriorated.
- the skin cleanser composition of the present invention is in a liquid crystal state at 25 ° C.
- the liquid crystal refers to hexagonal liquid crystal, lamellar liquid crystal, and cubic liquid crystal.
- hexagonal liquid crystals are preferable in terms of usability and a transparent appearance.
- a lamellar liquid crystal has a low viscosity and hangs down from the hand during use or thickens with added water, which may deteriorate the usability.
- liquid crystal is a molecular assembly of surfactants, and a liquid crystal state in which a cylindrical surfactant becomes a rod-like molecule due to the presence of an ionic polymer compound having a high concentration or an opposite charge.
- anisotropy based on this orientation order exhibited by the liquid crystal is “spontaneous” derived from the shape of the molecule and intermolecular force, and is not induced by any external force.
- a flow is applied to a concentrated solution of a polymer compound, molecular orientation occurs and optical anisotropy is observed. However, when the flow stops, such orientation is not spontaneous.
- Liquid crystals are extremely peculiar in that they have both liquid properties of fluidity and liquid crystal properties of optical anisotropy, and cannot be classified as solid or liquid. It is considered to be the “fourth state” of the substance.
- Component (B) is lauryldimethylaminoacetic acid betaine, and its content is 7 to 15% by mass in the skin cleanser composition.
- Component (C) consists of PEG-20 glyceryl triisostearate, PEG-20 glyceryl trioleate, PEG-20 trimethylolpropane triisostearate, POE (20-80) hydrogenated castor oil and POE (20-80) castor oil The content thereof is 2 to 5% by mass in the skin cleanser composition.
- Component (D) is a combination of propylene glycol and glycerin, propylene glycol or polyethylene glycol 400, and its content is 25 to 35% by mass in the skin cleanser composition. When propylene glycol and glycerin are used in combination Has a propylene glycol ratio of 20/80 or more.
- other appropriately selected components can be blended within a range that does not interfere with the object of the present invention.
- Other components can be appropriately selected from those commonly used in skin cleanser compositions, such as oils, silicones, alcohols such as lower or higher alcohols, lanolin derivatives, protein derivatives, acrylic resins.
- Dispersions, drugs such as vitamins, bactericides, antiseptics, pH adjusters such as potassium hydroxide and citric acid, antioxidants, sequestering agents, UV absorbers, animal and plant extracts or their derivatives, dyes, fragrances, pigments And water-insoluble polymer powder such as inorganic powder, clay mineral, nylon and polyethylene.
- the pH of the skin cleansing composition of the present invention is preferably 9.0 to 11.0 from the viewpoint of low temperature stability and liquid crystal formation, and more preferably 9.4 to 10.6 from the viewpoint of low temperature stability. .
- the pH is less than 9.0, the low-temperature stability may deteriorate, and when it exceeds 11.0, it may be difficult to form a liquid crystal.
- a skin cleanser composition was prepared as follows. Components (A), (C), (D) and purified water were weighed into a vessel of a vacuum emulsification kettle. Under reduced pressure, it was heated to 80 ° C. to dissolve. After dissolution, the component (B) was added and dissolved while stirring the paddle, cooled to 35 ° C. at 1 ° C./min in a reduced pressure state, and sufficiently depressurized and stirred for deaeration. After deaeration, cooling was performed to 25 ° C. at 1 ° C./min.
- the pH was measured using a pH meter HM-30R (manufactured by Toa DKK Co., Ltd.), and the target pH was set using potassium hydroxide or citric acid.
- the pH was measured after the electrode was immersed in a sample at 25 ° C. for 2 minutes. The following evaluation was performed about the obtained skin cleaning composition. The results are also shown in the table.
- the confirmation of the liquid crystal state was carried out using a polarizing microscope AX70 (Olympus Corporation) with the skin cleansing composition at 25 ° C.
- the interference pattern was observed as a scaly mosaic texture, it was a hexagonal liquid crystal, when a cross-shaped cross Nicol was observed, it was a lamellar liquid crystal, and when no interference pattern was observed, it was a micelle phase.
- the liquid crystal of the present invention refers to hexagonal liquid crystal, lamellar liquid crystal, and cubic liquid crystal.
- a hard transparent glass bottle (capacity 55 mL) with a height of 8 cm and a diameter of 3 cm is filled with 50 mL of the skin cleansing composition, stored in each environment at 50 ° C. and 0 ° C., observed for appearance at each storage temperature, and judged as follows: Based on the criteria, the stability of the skin cleanser composition was evaluated.
- a to B After storage for 4 weeks, there is no phase separation or precipitate, but a part of the appearance looks slightly cloudy.
- ⁇ After storage for 4 weeks, there is no phase separation or precipitates, but the appearance appears to be uniformly and slightly turbid.
- ⁇ No phase separation or precipitates after storage for 2 weeks, but phase separation or precipitates after storage for 4 weeks.
- X After storage for 2 weeks, there is phase separation or precipitate.
- 3 points The sample melts and foams 4 to 7 times after rubbing the palm.
- Standard of average score ⁇ : 4.5 to 5 points ⁇ to ⁇ : 4.0 points to less than 4.5 points ⁇ : 3.0 points to less than 4.0 points ⁇ : 2.0 points to less than 3.0 points ⁇ : 2 Less than 0 points
- bactericidal power tests were conducted on Examples 1 and 36.
- ⁇ Bactericidal power> (1) Preparation of Bacterial Solution A bacterial solution was prepared so that the initial number of the following bacteria was 10 8 / mL. Staphylococcus aureus: Staphylococcus aureus ATCC 6538 (2) Test solution The skin cleanser composition obtained in Examples 1 and 36 was diluted 5-fold with tap water to prepare a test solution.
- ⁇ Sterilizing power test method> At 25 ° C., 1 mL of the bacterial solution was added to 9 mL of the test solution and stirred sufficiently.
- SCDLP medium Soybean-Casein Broth with Lectin & Polysorbate 80: manufactured by Wako Pure Chemical Industries, Ltd.
- a 10-fold diluted solution was obtained.
- the same method was repeated to obtain each diluted solution. Collect 1.0 mL from each diluted solution in a petri dish, add 15 mL of SCDLP agar medium (Soybean-Casein Digest Age with Lectin & Polysorbate 80: manufactured by Wako Pure Chemical Industries, Ltd.), homogenize, and culture for 2 days (agar plate dilution) Method), colonies were counted and the number of viable bacteria was measured.
- Example 1 The bactericidal power of Example 1 is “ ⁇ 1.1”, the bactericidal power of Example 36 is “ ⁇ 3.2”, and the bactericidal power is improved by using a monoethanolamine salt as the component (A). Was confirmed. Further, Example 36 was “ ⁇ ” even at low temperature stability ( ⁇ 5 ° C., 1 month), and was excellent in low temperature stability.
- a skin cleanser composition was prepared as follows. Common components other than lauryldimethylaminoacetic acid betaine and flavor were weighed in a vessel of a vacuum emulsification kettle. Under reduced pressure, it was heated to 80 ° C. to dissolve. After dissolution, while stirring the paddle, lauryldimethylaminoacetic acid betaine was added and dissolved, and the mixture was cooled to 35 ° C. at 1 ° C./min under reduced pressure. At this time, degassing was performed by sufficiently reducing pressure and stirring. After deaeration, a fragrance was added and cooled to 25 ° C. at 1 ° C./min.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
Description
[1].下記(A)、(B)、(C)及び(D)成分を含有し、25℃において液晶状態であることを特徴とする皮膚洗浄剤組成物。
(A)炭素数8~26の高級脂肪酸塩15~45質量%
(B)ベタイン型両性界面活性剤7~25質量%
(C)下記非イオン性界面活性剤1~5質量%
ポリオキシエチレン(エチレンオキサイドの平均付加モル数10~80)グリセリル、グリセリン、又はポリオキシエチレン(エチレンオキサイドの平均付加モル数10~80)トリメチロールプロパンの3つの水酸基が、エステル化又はエーテル化された化合物であって、エステル化又はエーテル化部分は、炭素数7~25の飽和又は不飽和、直鎖又は分岐鎖の一価炭化水素基であり、水素原子の一部が水酸基で置換されていてもよく、この水酸基に平均付加モル数が10~80のポリオキシエチレンが付加されていてもよい、ただし、非イオン性界面活性剤に付加されるポリオキシエチレンの総数は、平均付加モル数で10~80である。
(D)多価アルコール15~35質量%
[2].(C)成分が、エステル化又はエーテル化部分の炭素数7~25の一価炭化水素基が、水素原子の一部が水酸基で置換されていることを特徴とする[1]記載の皮膚洗浄剤組成物。
[3].(C)成分が、ポリオキシエチレン硬化ヒマシ油又はポリオキシエチレンヒマシ油である[1]又は[2]記載の皮膚洗浄剤組成物。
[4].液晶が、ヘキサゴナル液晶である[1]、[2]又は[3]記載の皮膚洗浄剤組成物。 Accordingly, the present invention provides the following skin cleanser composition.
[1]. A skin cleanser composition containing the following components (A), (B), (C) and (D) and in a liquid crystal state at 25 ° C.
(A) 15 to 45% by mass of higher fatty acid salt having 8 to 26 carbon atoms
(B) Betaine amphoteric surfactant 7 to 25% by mass
(C) 1 to 5% by mass of the following nonionic surfactant
Three hydroxyl groups of polyoxyethylene (average added mole number of ethylene oxide 10 to 80) glyceryl, glycerin, or polyoxyethylene (average added mole number of ethylene oxide 10 to 80) trimethylolpropane are esterified or etherified. The esterified or etherified moiety is a saturated or unsaturated, linear or branched monovalent hydrocarbon group having 7 to 25 carbon atoms, and part of the hydrogen atoms are substituted with hydroxyl groups. The polyoxyethylene having an average addition mole number of 10 to 80 may be added to this hydroxyl group, provided that the total number of polyoxyethylene added to the nonionic surfactant is the average addition mole number. 10 to 80.
(D) 15 to 35% by mass of polyhydric alcohol
[2]. The skin cleanser according to [1], wherein the component (C) is a monovalent hydrocarbon group having 7 to 25 carbon atoms in the esterified or etherified moiety, wherein a part of the hydrogen atoms is substituted with a hydroxyl group Agent composition.
[3]. (C) The skin cleaning composition according to [1] or [2], wherein the component is polyoxyethylene hydrogenated castor oil or polyoxyethylene castor oil.
[4]. The skin cleanser composition according to [1], [2] or [3], wherein the liquid crystal is hexagonal liquid crystal.
本発明の皮膚洗浄剤組成物は、下記(A)、(B)、(C)及び(D)成分を含有し、25℃において液晶状態であることを特徴とする皮膚洗浄剤組成物である。
(A)炭素数8~26の高級脂肪酸塩15~45質量%
(B)ベタイン型両性界面活性剤7~25質量%
(C)下記非イオン性界面活性剤1~5質量%
ポリオキシエチレン(エチレンオキサイドの平均付加モル数10~80)グリセリル、グリセリン、又はポリオキシエチレン(エチレンオキサイドの平均付加モル数10~80)トリメチロールプロパンの3つの水酸基が、エステル化又はエーテル化された化合物であって、エステル化又はエーテル化部分は、炭素数7~25の飽和又は不飽和、直鎖又は分岐鎖の一価炭化水素基であり、水素原子の一部が水酸基で置換されていてもよく、この水酸基に平均付加モル数が10~80のポリオキシエチレンが付加されていてもよい、ただし、非イオン性界面活性剤に付加されるポリオキシエチレンの総数は、平均付加モル数で10~80である。
(D)多価アルコール15~35質量% Hereinafter, the present invention will be described in detail.
The skin cleanser composition of the present invention is a skin cleanser composition containing the following components (A), (B), (C) and (D) and being in a liquid crystal state at 25 ° C. .
(A) 15 to 45% by mass of higher fatty acid salt having 8 to 26 carbon atoms
(B) Betaine amphoteric surfactant 7 to 25% by mass
(C) 1 to 5% by mass of the following nonionic surfactant
Three hydroxyl groups of polyoxyethylene (average added mole number of ethylene oxide 10 to 80) glyceryl, glycerin, or polyoxyethylene (average added mole number of ethylene oxide 10 to 80) trimethylolpropane are esterified or etherified. The esterified or etherified moiety is a saturated or unsaturated, linear or branched monovalent hydrocarbon group having 7 to 25 carbon atoms, and part of the hydrogen atoms are substituted with hydroxyl groups. The polyoxyethylene having an average addition mole number of 10 to 80 may be added to this hydroxyl group, provided that the total number of polyoxyethylene added to the nonionic surfactant is the average addition mole number. 10 to 80.
(D) 15 to 35% by mass of polyhydric alcohol
本発明の(A)高級脂肪酸塩は炭素数8~26の高級脂肪酸塩であり、一価炭化水素基部分は、直鎖又は分岐鎖、飽和又は不飽和のいずれであってもよく、1種単独で又は2種以上を適宜組み合わせて用いることができる。中でも、下記一般式(1)で表される高級脂肪酸塩が好ましい。
R1COOM (1)
(式中、R1は、炭素数7~25の直鎖又は分岐鎖、飽和又は不飽和の一価炭化水素基を示し、この一価炭化水素基の水素原子の一部又は全部が水酸基で置換されていてもよい。Mは、カリウム、ナトリウム、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、2-アミノ-2-メチル-1-プロパノール又はジイソプロパノールアミンを示す。) (A) Higher fatty acid salt The (A) higher fatty acid salt of the present invention is a higher fatty acid salt having 8 to 26 carbon atoms, and the monovalent hydrocarbon group moiety is either linear or branched, saturated or unsaturated. It may be used alone or in combination of two or more. Among these, higher fatty acid salts represented by the following general formula (1) are preferable.
R 1 COOM (1)
(In the formula, R 1 represents a linear or branched, saturated or unsaturated monovalent hydrocarbon group having 7 to 25 carbon atoms, and part or all of the hydrogen atoms of the monovalent hydrocarbon group are hydroxyl groups. (M may be potassium, sodium, monoethanolamine, diethanolamine, triethanolamine, 2-amino-2-methyl-1-propanol or diisopropanolamine.)
ベタイン型両性界面活性剤としては、例えば、イミダゾリン型(アミドアミン型)、カルボベタイン型、スルホベタイン型、ホスホベタイン型等が挙げられる。これらは1種単独で又は2種以上を適宜組み合わせて用いることができる。これらの中でも、液晶を形成しやすい点で、カルボベタイン型が好ましい。 (B) Betaine-type amphoteric surfactant Examples of the betaine-type amphoteric surfactant include imidazoline type (amidoamine type), carbobetaine type, sulfobetaine type, and phosphobetaine type. These can be used individually by 1 type or in combination of 2 or more types. Among these, the carbobetaine type is preferable in that it easily forms liquid crystals.
本発明の(C)成分は、ポリオキシエチレン(エチレンオキサイドの平均付加モル数10~80)グリセリル、グリセリン、又はポリオキシエチレン(エチレンオキサイドの平均付加モル数10~80)トリメチロールプロパンの3つの水酸基が、エステル化又はエーテル化された化合物であって、エステル化又はエーテル化部分は、炭素数7~25の飽和又は不飽和、直鎖又は分岐鎖の一価炭化水素基であり、水素原子の一部が水酸基で置換されていてもよく、この水酸基に平均付加モル数が10~80のポリオキシエチレンが付加されていてもよい、ただし、非イオン性界面活性剤に付加されるポリオキシエチレンの総数は、平均付加モル数で10~80である。 (C) The following nonionic surfactant The component (C) of the present invention contains polyoxyethylene (average added mole number of ethylene oxide 10 to 80) glyceryl, glycerin, or polyoxyethylene (average added mole number of ethylene oxide) 10 to 80) A compound in which three hydroxyl groups of trimethylolpropane are esterified or etherified, and the esterified or etherified moiety is a saturated or unsaturated, linear or branched chain having 7 to 25 carbon atoms. It is a monovalent hydrocarbon group, a part of hydrogen atoms may be substituted with a hydroxyl group, and polyoxyethylene having an average addition mole number of 10 to 80 may be added to this hydroxyl group, provided that it is nonionic The total number of polyoxyethylenes added to the surfactant is 10-80 in terms of the average number of moles added.
トリイソステアリン酸PEG-20グリセリル(日本エマルジョン、GWIS-320)HLB=8
トリステアリン酸PEG-20グリセリル(日本エマルジョン、GWS-320、HLB=8)
トリオレイン酸PEG-20グリセリル(日本エマルジョン、GWO-320、HLB=8)
トリイソステアリン酸PEG-20トリメチロールプロパン(日本エマルジョン、TPIS-320、HLB=8)
POE(20)ヒマシ油(日本エマルジョン、C-20、HLB=9)
POE(10)硬化ヒマシ油(日本エマルジョン、HC-10、HLB=7)
POE(10)硬化ヒマシ油(日光ケミカルズ、HCO-10、HLB=6.5)
POE(20)硬化ヒマシ油(日本エマルジョン、HC-20、HLB=9)
POE(20)硬化ヒマシ油(日光ケミカルズ、HCO-20、HLB=10.5)
POE(40)硬化ヒマシ油(日本エマルジョン、HC-40、HLB=12)
POE(40)硬化ヒマシ油(日光ケミカルズ、HCO-40、HLB=12.5)
POE(80)硬化ヒマシ油(日本エマルジョン、HC-80、HLB=15)
POE(80)硬化ヒマシ油(日光ケミカルズ、HCO-80、HLB=15.0) Specific examples include the following. Hereinafter, PEG represents polyethylene glycol, and POE represents polyoxyethylene. For example, POE (20) shows an average addition mole number of polyoxyethylene of 20.
PEG-20 glyceryl triisostearate (Japan emulsion, GWIS-320) HLB = 8
PEG-20 glyceryl tristearate (Japan Emulsion, GWS-320, HLB = 8)
PEG-20 glyceryl trioleate (Japan Emulsion, GWO-320, HLB = 8)
PEG-20 trimethylolpropane triisostearate (Japan emulsion, TPIS-320, HLB = 8)
POE (20) castor oil (Japanese emulsion, C-20, HLB = 9)
POE (10) hydrogenated castor oil (Japan emulsion, HC-10, HLB = 7)
POE (10) hydrogenated castor oil (Nikko Chemicals, HCO-10, HLB = 6.5)
POE (20) hydrogenated castor oil (Japan emulsion, HC-20, HLB = 9)
POE (20) hydrogenated castor oil (Nikko Chemicals, HCO-20, HLB = 10.5)
POE (40) hydrogenated castor oil (Japan emulsion, HC-40, HLB = 12)
POE (40) hydrogenated castor oil (Nikko Chemicals, HCO-40, HLB = 12.5)
POE (80) hydrogenated castor oil (Japan emulsion, HC-80, HLB = 15)
POE (80) hydrogenated castor oil (Nikko Chemicals, HCO-80, HLB = 15.0)
多価アルコールとしては、2~6価のものが好ましく、エチレングリコール、ジエチレングリコール、ポリエチレングリコール200(医薬部外品原料規格2006相当品)、ポリエチレングリコール300(医薬部外品原料規格2006相当品)、ポリエチレングリコール400(医薬部外品原料規格2006相当品)、ポリエチレングリコール600(医薬部外品原料規格2006相当品)、プロピレングリコール、ジプロピレングリコール、1,3-ブチレングリコール、イソペンチルジオール、ペンチレングリコール、1,2-ヘキサンジオール、ヘキシレングリコール、グリセリン、ジグリセリン、ソルビット、キシリトール、マンニトール等が好ましく、これらは1種単独で又は2種以上を適宜組み合わせて用いることができる。なお、ここでポリエチレグリコールとは、化粧品原料基準第二版注解、医薬部外品原料規格2006、日本薬局方医薬品規格2002、第15改定日本薬局方に定められたものに相当する。中でも、液晶の形成しやすさの点から、プロピレングリコール、ポリエチレングリコール200、ポリエチレングリコール300、ポリエチレングリコール400、ポリエチレングリコール600、プロピレングリコール、グリセリン、ソルビットが好ましい。さらに、低温安定性と液晶を形成しやすい点から、2価と3価の多価アルコールの混合がより好ましく、プロピレングリコールとグリセリンとの組み合わせがさらに好ましく、プロピレングリコールの質量(%)/グリセリンの質量(%)が、20/80~50/50が特に好ましい。プロピレングリコールの比率が、50/50を超えると、液晶形成性が低下し、高温安定性が低下する場合があり、20/80未満であると粘度が高すぎる場合がある。 (D) Polyhydric alcohol The polyhydric alcohol is preferably a dihydric to hexahydric one, such as ethylene glycol, diethylene glycol, polyethylene glycol 200 (a quasi-drug raw material standard 2006 equivalent), polyethylene glycol 300 (a quasi-drug raw material). Standard 2006 equivalent), polyethylene glycol 400 (quasi-drug raw material standard 2006 equivalent), polyethylene glycol 600 (quasi-drug raw material standard 2006 equivalent), propylene glycol, dipropylene glycol, 1,3-butylene glycol, Isopentyldiol, pentylene glycol, 1,2-hexanediol, hexylene glycol, glycerin, diglycerin, sorbit, xylitol, mannitol and the like are preferable, and these are used alone or in appropriate combination of two or more. Can be used. Here, the polyethylene glycol corresponds to those defined in Cosmetic Material Standard 2nd Edition Comment, Quasi-drug Raw Material Standard 2006, Japanese Pharmacopoeia Pharmaceutical Standard 2002, 15th revised Japanese Pharmacopoeia. Among these, propylene glycol, polyethylene glycol 200, polyethylene glycol 300, polyethylene glycol 400, polyethylene glycol 600, propylene glycol, glycerin, and sorbit are preferable from the viewpoint of easy formation of liquid crystals. Furthermore, from the viewpoint of low temperature stability and easy formation of liquid crystals, a mixture of divalent and trivalent polyhydric alcohols is more preferable, a combination of propylene glycol and glycerin is more preferable, and the mass (%) of propylene glycol / glycerin The mass (%) is particularly preferably 20/80 to 50/50. When the ratio of propylene glycol exceeds 50/50, the liquid crystal formability may be lowered and high-temperature stability may be lowered, and when it is less than 20/80, the viscosity may be too high.
(A)成分の含有量は、皮膚洗浄剤組成物中20~35質量%であり、炭素数が12以下の高級脂肪酸塩と炭素数が14以上の高級脂肪酸塩の質量比は80/20~50/50である。
(B)成分はラウリルジメチルアミノ酢酸ベタインであり、その含有量は、皮膚洗浄剤組成物中7~15質量%である。
(C)成分は、トリイソステアリン酸PEG-20グリセリル、トリオレイン酸PEG-20グリセリル、トリイソステアリン酸PEG-20トリメチロールプロパン、POE(20~80)硬化ヒマシ油及びPOE(20~80)ヒマシ油から選ばれ、その含有量は、皮膚洗浄剤組成物中2~5質量%である。
(D)成分は、プロピレングリコールとグリセリンとの併用、プロピレングリコール又はポリエチレングリコール400であり、その含有量は、皮膚洗浄剤組成物中25~35質量%であり、プロピレングリコールとグリセリンを併用する場合は、プロピレングリコールの比率が20/80以上である。 In addition, it is preferable that a skin cleansing composition is transparent from the beauty of appearance etc. Note that “transparent” means “「 ”and“ ◯ ”in the evaluation criteria in the measurement of <Transparency> in Examples described later. In the measurement of <Transparency> in Examples described later, in order to obtain a “transparent” composition having a transparency of ◎, the components (A) to (D) preferably satisfy the following conditions.
The content of the component (A) is 20 to 35% by mass in the skin cleanser composition, and the mass ratio of the higher fatty acid salt having 12 or less carbon atoms and the higher fatty acid salt having 14 or more carbon atoms is 80/20 to 50/50.
Component (B) is lauryldimethylaminoacetic acid betaine, and its content is 7 to 15% by mass in the skin cleanser composition.
Component (C) consists of PEG-20 glyceryl triisostearate, PEG-20 glyceryl trioleate, PEG-20 trimethylolpropane triisostearate, POE (20-80) hydrogenated castor oil and POE (20-80) castor oil The content thereof is 2 to 5% by mass in the skin cleanser composition.
Component (D) is a combination of propylene glycol and glycerin, propylene glycol or polyethylene glycol 400, and its content is 25 to 35% by mass in the skin cleanser composition. When propylene glycol and glycerin are used in combination Has a propylene glycol ratio of 20/80 or more.
皮膚洗浄剤組成物を以下のように調製した。(A)、(C)、(D)成分及び精製水を真空乳化釜のベッセルに秤取した。減圧状態で、80℃に加温して溶解した。溶解後、パドルを攪拌しながら、(B)成分を加え溶解し、減圧状態で1℃/分で35℃まで冷却し、充分に減圧・攪拌を行い脱気した。脱気後、25℃まで1℃/分で冷却を行った。続いてpHメーターHM-30R(東亜ディーケーケー株式会社製)を用いてpHを測定し、水酸化カリウム又はクエン酸を用いて、目標のpHとした。なお、pHは、25℃にしたサンプルに、電極を2分間浸した後の値を測定した。得られた皮膚洗浄剤組成物について、下記評価を行った。結果を表中に併記する。 [Examples 1 to 38, Comparative Examples 1 to 12]
A skin cleanser composition was prepared as follows. Components (A), (C), (D) and purified water were weighed into a vessel of a vacuum emulsification kettle. Under reduced pressure, it was heated to 80 ° C. to dissolve. After dissolution, the component (B) was added and dissolved while stirring the paddle, cooled to 35 ° C. at 1 ° C./min in a reduced pressure state, and sufficiently depressurized and stirred for deaeration. After deaeration, cooling was performed to 25 ° C. at 1 ° C./min. Subsequently, the pH was measured using a pH meter HM-30R (manufactured by Toa DKK Co., Ltd.), and the target pH was set using potassium hydroxide or citric acid. The pH was measured after the electrode was immersed in a sample at 25 ° C. for 2 minutes. The following evaluation was performed about the obtained skin cleaning composition. The results are also shown in the table.
BH型粘度計(株式会社東京計器製)を用いて、試料温度25℃にて、ローターNo.7、回転数4rpm、1分間後の粘度を測定した。 <viscosity>
Using a BH type viscometer (manufactured by Tokyo Keiki Co., Ltd.), the sample temperature was 25 ° C. and the rotor No. 7. Viscosity after 1 minute at 4 rpm was measured.
液晶状態の確認は、皮膚洗浄剤組成物を25℃にし、偏光顕微鏡AX70(オリンパス(株))を用いて観察した。干渉紋がうろこ状のモザイクテクスチャーとして観察された場合をヘキサゴナル液晶、十字模様のクロスニコルが観察された場合はラメラ液晶、干渉紋が見られない場合はミセル相とした。本発明の液晶は、ヘキサゴナル液晶、ラメラ液晶、キュービック液晶をいう。これらの典型的な干渉紋様はR.B.Rosevere, “The microscopy of the Liquid Crystalline Neat and Middle Phase of soaps and synthetic detergents” J. Am. Oil Chemist’s Soc., 628, 31 (1954)等に例示されている。なお、25℃で固形物の分散が見られる場合には、これらの干渉紋が見られても、液晶相とは判断しなかった。
一方、非常に粘性が高く干渉紋が見られないキュービック液晶層の判定や、偏光顕微鏡で判断しにくい場合は、小角用受光ユニットとX線集光ミラーを取り付けたX線回折装置X’ Pert Pro(PANalitical社)を用いて、小角部分のX線散乱の干渉パターンから判断した。(100),(110)、(200)面に対応して、1:√3:2:・・・の面間距離比に対応する散乱角にピークが現れるものをヘキサゴナル液晶相、(100)、(200)、(300)面に対応して1:2:3:・・・の面間隔比に対応する散乱角にピークが現れるものをラメラ液晶、(100)、(111)、(200)面の面間隔に対応した1:√3/2:√2:・・・・や、(211)、(220)、(321)、(400)面に対応した1:√4/3:√7/3:√8/3:・・・にピークが現れるものをキュービック液晶とした。また、小角部分のx線散乱に明確なピークが見られず、散乱ベクトルq=0.1~0.5nm-1付近にブロードなピークが見られる場合には、ミセル相とした。表中に下記記号で示した。
ラメラ液晶:L
キュービック層:C
ヘキサゴナル液晶:H
ミセル:M
固体分散:S <Checking the LCD status>
The confirmation of the liquid crystal state was carried out using a polarizing microscope AX70 (Olympus Corporation) with the skin cleansing composition at 25 ° C. When the interference pattern was observed as a scaly mosaic texture, it was a hexagonal liquid crystal, when a cross-shaped cross Nicol was observed, it was a lamellar liquid crystal, and when no interference pattern was observed, it was a micelle phase. The liquid crystal of the present invention refers to hexagonal liquid crystal, lamellar liquid crystal, and cubic liquid crystal. These typical interference patterns are exemplified in RBRosevere, “The microscopy of the Liquid Crystalline Neat and Middle Phase of soaps and synthetic detergents” J. Am. Oil Chemist's Soc., 628, 31 (1954). In addition, when dispersion | distribution of the solid substance was seen at 25 degreeC, even if these interference patterns were seen, it was not judged as a liquid crystal phase.
On the other hand, if it is difficult to determine a cubic liquid crystal layer that is very viscous and has no interference pattern, or if it is difficult to determine with a polarizing microscope, an X-ray diffractometer X 'Pert Pro with a small-angle light receiving unit and an X-ray condenser mirror (PANalitical) was used to determine from the X-ray scattering interference pattern in the small-angle part. Corresponding to the (100), (110), (200) planes, a hexagonal liquid crystal phase having a peak at a scattering angle corresponding to the inter-plane distance ratio of 1: √3: 2:... (100) , (200), (300) corresponding to the plane spacing ratio of 1: 2: 3:..., Lamellar liquid crystal, (100), (111), (200 ) 1: √3 / 2 corresponding to the surface spacing of the surfaces: √2:..., And 1: √4 / 3 corresponding to the (211), (220), (321), (400) surfaces: A liquid crystal having a peak at √7 / 3: √8 / 3:. In addition, when no clear peak was observed in the x-ray scattering in the small-angle portion and a broad peak was observed in the vicinity of the scattering vector q = 0.1 to 0.5 nm −1 , the micelle phase was set. The following symbols are used in the table.
Lamella liquid crystal: L
Cubic layer: C
Hexagonal liquid crystal: H
Micelle: M
Solid dispersion: S
高さ8cm、口径3cmの硬質透明ガラス瓶(容量55mL)に、皮膚洗浄剤組成物を50mL充填し、50℃・0℃の各環境下において保存し、各保存温度における外観を観察し、下記判断基準に基づき、皮膚洗浄剤組成物の安定性を評価した。
[判断基準]
◎:4週間保存後、相分離や析出物がなく、透明で、均一な状態。
◎~○:4週間保存後、相分離や析出物がないが、外観の一部がわずかに濁ってみえる。
○:4週間保存後、相分離や析出物がないが、外観が均一にわずかに濁ってみえる。
△:2週間保存後は相分離や析出物がないが、4週間保存後、相分離又は析出物がある。
×:2週間保存後、相分離又は析出物がある。 <High temperature / low temperature stability>
A hard transparent glass bottle (capacity 55 mL) with a height of 8 cm and a diameter of 3 cm is filled with 50 mL of the skin cleansing composition, stored in each environment at 50 ° C. and 0 ° C., observed for appearance at each storage temperature, and judged as follows: Based on the criteria, the stability of the skin cleanser composition was evaluated.
[Judgment criteria]
A: After storage for 4 weeks, it is transparent and uniform with no phase separation or precipitates.
A to B: After storage for 4 weeks, there is no phase separation or precipitate, but a part of the appearance looks slightly cloudy.
○: After storage for 4 weeks, there is no phase separation or precipitates, but the appearance appears to be uniformly and slightly turbid.
Δ: No phase separation or precipitates after storage for 2 weeks, but phase separation or precipitates after storage for 4 weeks.
X: After storage for 2 weeks, there is phase separation or precipitate.
高さ8cm、口径3cmの硬質透明ガラス瓶(容量55mL)に、皮膚洗浄剤組成物を50mL(高さ6cm)充填し、25℃の環境下に1日保存した。MSゴシック体で「あ」と印刷した紙の上に、各試料を充填した上記ガラス瓶を置き、ガラス瓶の上から紙に印刷された文字の判別性を下記判断基準に基づき、皮膚洗浄剤組成物の透明度を評価した。
[判断基準]
◎:MSゴシック体20ポントで印刷した「あ」が、明確に判別できる。
○:MSゴシック体20ポントで印刷した「あ」が、ぼやけてみえるが、判別できる。
△:MSゴシック体20ポントで印刷した「あ」は判別できないが、24ポントで印刷した「あ」は、判別できる。
×:MSゴシック体24ポントで印刷した「あ」が判別できない。 <Transparency>
A hard transparent glass bottle (capacity 55 mL) having a height of 8 cm and a diameter of 3 cm was filled with 50 mL (6 cm in height) of the skin cleansing composition and stored in an environment at 25 ° C. for one day. The above glass bottle filled with each sample is placed on a paper printed with MS Gothic "A", and the skin cleansing composition is based on the following criteria for the discrimination of characters printed on the paper from the top of the glass bottle The transparency of was evaluated.
[Judgment criteria]
A: “A” printed with 20 points of MS Gothic body can be clearly identified.
○: “A” printed with 20 points of MS Gothic font appears blurry but can be distinguished.
Δ: “A” printed with 20 points of MS Gothic cannot be discriminated, but “A” printed with 24 points can be discriminated.
X: “A” printed with 24 points of MS Gothic cannot be identified.
使用時の皮膚洗浄剤組成物の溶け易さは、専門評価パネル10名が、皮膚洗浄剤組成物を使用して評価した。チューブ容器(直径3cm、高さ8cm、口径5mm)に皮膚洗浄剤組成物を充填し、水で濡らした手のひらに各試料1gをとり、両手で延ばして泡立てて、溶け易さを評価した。評価は、下記に示す判断基準に基づき5段階の評点を付け、各試料の評点の平均値をとり、平均値から下記基準に基づいて行った。
[判断基準]
5点:手のひらをこすりはじめと同時に試料が溶けて、泡立つ。
4点:手のひらをこすりはじめて2~3回で試料が溶けて、泡立つ。
3点:手のひらをこすりはじめて4~7回で試料が溶けて、泡立つ。
2点:手のひらをこすりはじめて、8~12回で試料が溶けて、泡立つ。
1点:手から試料剤が滑り落ちるか、手のひらや指に試料が付着して、13回以上手のひらをこすっても泡立たせることができない。
[評点平均値の基準]
◎ :4.5点~5点
◎~〇:4.0点~4.5点未満
○ :3.0点~4.0点未満
△ :2.0点~3.0点未満
× :2.0点未満 <Ease of melting during use>
The ease of dissolution of the skin cleanser composition during use was evaluated by 10 professional evaluation panels using the skin cleanser composition. A tube container (3 cm in diameter, 8 cm in height, 5 mm in diameter) was filled with the skin cleanser composition, 1 g of each sample was taken into the palm wetted with water, and foamed by extending with both hands, and the ease of melting was evaluated. Evaluation was made based on the following criteria based on the following criteria based on the five-point score based on the following criteria.
[Judgment criteria]
5 points: At the same time as rubbing the palm, the sample melts and foams.
4 points: The sample melts and foams 2 to 3 times after rubbing the palm.
3 points: The sample melts and foams 4 to 7 times after rubbing the palm.
2 points: Starting to rub the palm, the sample melts and bubbles in 8-12 times.
1 point: The sample agent slides down from the hand, or the sample adheres to the palm or finger, and even if the palm is rubbed 13 times or more, foaming cannot be made.
[Standard of average score]
◎: 4.5 to 5 points ◎ to ○: 4.0 points to less than 4.5 points ○: 3.0 points to less than 4.0 points Δ: 2.0 points to less than 3.0 points ×: 2 Less than 0 points
〈殺菌力〉
(1)菌液の調製
下記菌を初発菌数が10の8乗個/mLとなるように菌液を調製した。
黄色ブドウ球菌:スタフィロコッカス アウレウス(Staphylococcus aureus)ATCC6538
(2)試験液
実施例1,36で得られた皮膚洗浄剤組成物を水道水で5倍に希釈し、試験液を調製した。
〈殺菌力試験法〉
25℃にて、試験液9mLに菌液1mLを添加して充分撹拌し、添加1分後に4.5mLのSCDLP培地(Soybean-Casein Digest Broth with Lectin&Polysorbate 80:和光純薬工業(株)製)に加え、10倍希釈液とした。同様の方法を繰り返して各希釈液を得た。各希釈液から1.0mLをシャーレに採取し、SCDLP寒天培地(Soybean-Casein Digest Ager with Lectin&Polysorbate 80:和光純薬工業(株)製)15mLを加えて均一化し、2日間培養し(寒天平板希釈法)、コロニーをカウントして生存菌数を測定した。初発菌数と生存菌数から、下記式に基づいて殺菌力を算出し、下記評価基準で殺菌効果を評価した。
殺菌力=log(生存菌数/初発菌数)
なお、殺菌力は数値が小さいほど効果が高い。 In addition, in order to confirm the bactericidal power of the skin cleansing composition of the present invention, the following bactericidal power tests were conducted on Examples 1 and 36.
<Bactericidal power>
(1) Preparation of Bacterial Solution A bacterial solution was prepared so that the initial number of the following bacteria was 10 8 / mL.
Staphylococcus aureus: Staphylococcus aureus ATCC 6538
(2) Test solution The skin cleanser composition obtained in Examples 1 and 36 was diluted 5-fold with tap water to prepare a test solution.
<Sterilizing power test method>
At 25 ° C., 1 mL of the bacterial solution was added to 9 mL of the test solution and stirred sufficiently. One minute after the addition, 4.5 mL of SCDLP medium (Soybean-Casein Broth with Lectin & Polysorbate 80: manufactured by Wako Pure Chemical Industries, Ltd.) In addition, a 10-fold diluted solution was obtained. The same method was repeated to obtain each diluted solution. Collect 1.0 mL from each diluted solution in a petri dish, add 15 mL of SCDLP agar medium (Soybean-Casein Digest Age with Lectin & Polysorbate 80: manufactured by Wako Pure Chemical Industries, Ltd.), homogenize, and culture for 2 days (agar plate dilution) Method), colonies were counted and the number of viable bacteria was measured. Based on the following formula, bactericidal power was calculated from the initial bacterial count and viable bacterial count, and the bactericidal effect was evaluated according to the following evaluation criteria.
Bactericidal power = log (number of viable bacteria / number of initial bacteria)
In addition, the effect is so high that a sterilization power is small.
皮膚洗浄剤組成物を以下のように調製した。ラウリルジメチルアミノ酢酸ベタイン及び香料以外の共通成分を真空乳化釜のベッセルに秤取した。減圧状態で、80℃に加温して溶解した。溶解後、パドルを攪拌しながら、ラウリルジメチルアミノ酢酸ベタインを加え溶解し、減圧状態で1℃/分で35℃まで冷却した。この時点で、充分に減圧・攪拌を行い脱気した。脱気後、香料を添加し、25℃まで1℃/分で冷却を行った。続いてpHメーターHM-30R(東亜ディーケーケー株式会社製)を用いてpHを測定し、水酸化カリウム又はクエン酸を用いて、目標のpHとした。
組成 %
ラウリン酸カリウム 21
ミリスチン酸カリウム 9
ラウリルジメチルアミノ酢酸ベタイン*1 9
ポリオキシエチレン硬化ヒマシ油(E.O.20)*10 3
プロピレングリコール 9
グリセリン 21
イソプロピルメチルフェノール*19 0.1
モノエタノールアミン 0.5
エデト酸 0.1
ビタミンE*20 0.1
ポリエチレン末*21 0.3
香料 0.4
精製水 残部
合計 100.0
水酸化カリウム(48%)又はクエン酸で、pHを10.2に調整した。
〈評価結果〉
粘度:118Pa・s
透明度:◎
結晶相:H
安定性(50℃):◎
安定性(0℃):◎
安定性(-5℃):◎ [Example 39]
A skin cleanser composition was prepared as follows. Common components other than lauryldimethylaminoacetic acid betaine and flavor were weighed in a vessel of a vacuum emulsification kettle. Under reduced pressure, it was heated to 80 ° C. to dissolve. After dissolution, while stirring the paddle, lauryldimethylaminoacetic acid betaine was added and dissolved, and the mixture was cooled to 35 ° C. at 1 ° C./min under reduced pressure. At this time, degassing was performed by sufficiently reducing pressure and stirring. After deaeration, a fragrance was added and cooled to 25 ° C. at 1 ° C./min. Subsequently, the pH was measured using a pH meter HM-30R (manufactured by Toa DKK Co., Ltd.), and the target pH was set using potassium hydroxide or citric acid.
Composition%
Potassium laurate 21
Potassium myristate 9
Lauryldimethylaminoacetic acid betaine * 1 9
Polyoxyethylene hydrogenated castor oil (E.O.20) * 10 3
Propylene glycol 9
Glycerin 21
Isopropyl methylphenol * 19 0.1
Monoethanolamine 0.5
Edetic acid 0.1
Vitamin E * 20 0.1
Polyethylene powder * 21 0.3
Fragrance 0.4
Purified water balance 100.0
The pH was adjusted to 10.2 with potassium hydroxide (48%) or citric acid.
<Evaluation results>
Viscosity: 118 Pa · s
Transparency: ◎
Crystal phase: H
Stability (50 ° C): ◎
Stability (0 ° C): ◎
Stability (-5 ° C): ◎
*1:アモーゲンSH(第一工業製薬)
*2:アモーゲンSHをステンレスバットに取り、真空乾燥機(40℃)にて乾燥し、純分量を80%に濃縮したもの。
*3:LPB-R(一方社油脂工業)
*4:エマレックスGWIS-320(日本エマルジョン、HLB=8)
*5:GWS-320(日本エマルジョン、HLB=8)
*6:GWO-320(日本エマルジョン、HLB=8)
*7:TPIS-320(日本エマルジョン、HLB=8)
*8:C-20(日本エマルジョン、HLB=9)
*9:HC-10(日本エマルジョン、HLB=7)
*10:HC-20(日本エマルジョン、HLB=9)
*11:HC-40(日本エマルジョン、HLB=12)
*12:HC-80(日本エマルジョン、HLB=15)
*13:PEG#400K(ライオン)
*14:NEOSORB70/02SB(ロケットジャパン)
*15:HC-5(日本エマルジョン、HLB=5)
*16:HC-100(日本エマルジョン、HLB=15)
*17:GWIS-220EX(日本エマルジョン、HLB=10)
*18:GWIS-120(日本エマルジョン、HLB=13)
*19:IPMP(大阪化成)
*20:dl-αトコフェロール(DSMニュートリションジャパン)
*21:フロービーズCL-8007(住友精化)
*22:化粧品用濃グリセリン The raw materials used in preparing the examples and comparative examples are shown below.
* 1: Amorgen SH (Daiichi Kogyo Seiyaku)
* 2: Ammogen SH is taken in a stainless steel vat, dried with a vacuum dryer (40 ° C), and the pure content is concentrated to 80%.
* 3: LPB-R (one company oil industry)
* 4: EMALEX GWIS-320 (Japan Emulsion, HLB = 8)
* 5: GWS-320 (Japan emulsion, HLB = 8)
* 6: GWO-320 (Japan emulsion, HLB = 8)
* 7: TPIS-320 (Japan emulsion, HLB = 8)
* 8: C-20 (Japan emulsion, HLB = 9)
* 9: HC-10 (Japan emulsion, HLB = 7)
* 10: HC-20 (Japan emulsion, HLB = 9)
* 11: HC-40 (Japan emulsion, HLB = 12)
* 12: HC-80 (Japan emulsion, HLB = 15)
* 13: PEG # 400K (Lion)
* 14: NEOSORB70 / 02SB (Rocket Japan)
* 15: HC-5 (Japan emulsion, HLB = 5)
* 16: HC-100 (Japan emulsion, HLB = 15)
* 17: GWIS-220EX (Japan emulsion, HLB = 10)
* 18: GWIS-120 (Japan emulsion, HLB = 13)
* 19: IPMP (Osaka Kasei)
* 20: dl-α Tocopherol (DSM Nutrition Japan)
* 21: Flow beads CL-8007 (Sumitomo Seika)
* 22: Concentrated glycerin for cosmetics
Claims (4)
- 下記(A)、(B)、(C)及び(D)成分を含有し、25℃において液晶状態であることを特徴とする皮膚洗浄剤組成物。
(A)炭素数8~26の高級脂肪酸塩15~45質量%
(B)ベタイン型両性界面活性剤7~25質量%
(C)下記非イオン性界面活性剤1~5質量%
ポリオキシエチレン(エチレンオキサイドの平均付加モル数10~80)グリセリル、グリセリン、又はポリオキシエチレン(エチレンオキサイドの平均付加モル数10~80)トリメチロールプロパンの3つの水酸基が、エステル化又はエーテル化された化合物であって、エステル化又はエーテル化部分は、炭素数7~25の飽和又は不飽和、直鎖又は分岐鎖の一価炭化水素基であり、水素原子の一部が水酸基で置換されていてもよく、この水酸基に平均付加モル数が10~80のポリオキシエチレンが付加されていてもよい、ただし、非イオン性界面活性剤に付加されるポリオキシエチレンの総数は、平均付加モル数で10~80である。
(D)多価アルコール15~35質量% A skin cleanser composition containing the following components (A), (B), (C) and (D) and in a liquid crystal state at 25 ° C.
(A) 15 to 45% by mass of higher fatty acid salt having 8 to 26 carbon atoms
(B) Betaine amphoteric surfactant 7 to 25% by mass
(C) 1 to 5% by mass of the following nonionic surfactant
Three hydroxyl groups of polyoxyethylene (average added mole number of ethylene oxide 10 to 80) glyceryl, glycerin, or polyoxyethylene (average added mole number of ethylene oxide 10 to 80) trimethylolpropane are esterified or etherified. The esterified or etherified moiety is a saturated or unsaturated, linear or branched monovalent hydrocarbon group having 7 to 25 carbon atoms, and part of the hydrogen atoms are substituted with hydroxyl groups. The polyoxyethylene having an average addition mole number of 10 to 80 may be added to this hydroxyl group, provided that the total number of polyoxyethylene added to the nonionic surfactant is the average addition mole number. 10 to 80.
(D) 15 to 35% by mass of polyhydric alcohol - (C)成分が、エステル化又はエーテル化部分の炭素数7~25の一価炭化水素基が、水素原子の一部が水酸基で置換されていることを特徴とする請求項1記載の皮膚洗浄剤組成物。 The skin cleanser according to claim 1, wherein the component (C) is a monovalent hydrocarbon group having 7 to 25 carbon atoms in the esterified or etherified moiety, wherein a part of the hydrogen atoms is substituted with a hydroxyl group. Agent composition.
- (C)成分が、ポリオキシエチレン硬化ヒマシ油又はポリオキシエチレンヒマシ油である請求項1又は2記載の皮膚洗浄剤組成物。 The skin cleansing composition according to claim 1 or 2, wherein the component (C) is polyoxyethylene hydrogenated castor oil or polyoxyethylene castor oil.
- 液晶が、ヘキサゴナル液晶である請求項1、2又は3記載の皮膚洗浄剤組成物。 4. The skin cleanser composition according to claim 1, 2 or 3, wherein the liquid crystal is hexagonal liquid crystal.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020137006662A KR101790822B1 (en) | 2010-09-21 | 2011-09-16 | Skin cleanser composition |
JP2012535019A JP5861639B2 (en) | 2010-09-21 | 2011-09-16 | Skin cleanser composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010-210990 | 2010-09-21 | ||
JP2010210990 | 2010-09-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012039350A1 true WO2012039350A1 (en) | 2012-03-29 |
Family
ID=45873837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2011/071189 WO2012039350A1 (en) | 2010-09-21 | 2011-09-16 | Skin cleanser composition |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5861639B2 (en) |
KR (1) | KR101790822B1 (en) |
TW (1) | TWI515013B (en) |
WO (1) | WO2012039350A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021078412A1 (en) * | 2019-10-21 | 2021-04-29 | Jallal Messadek | Fractal formulations |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102099325B1 (en) * | 2014-11-24 | 2020-04-09 | 주식회사 엘지생활건강 | Skin cleansing composition |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01151510A (en) * | 1987-12-09 | 1989-06-14 | Lion Corp | Detergent composition |
JPH0762389A (en) * | 1993-06-18 | 1995-03-07 | Shiseido Co Ltd | Detergent composition |
JPH09279192A (en) * | 1996-04-09 | 1997-10-28 | Nof Corp | Transparent gel-like cleansing agent composition |
JP2005008682A (en) * | 2003-06-17 | 2005-01-13 | Pola Chem Ind Inc | Cream-like detergent |
JP2007169248A (en) * | 2005-12-26 | 2007-07-05 | Lion Corp | Liquid skin cleanser composition |
JP2007211232A (en) * | 2005-10-31 | 2007-08-23 | Kao Corp | Thickening/foam boosting agent |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6357699A (en) * | 1986-08-28 | 1988-03-12 | 株式会社資生堂 | Transparent gel like composition |
JPH07215841A (en) * | 1994-01-31 | 1995-08-15 | Shiseido Co Ltd | Skin-cleansing agent |
JP4667164B2 (en) * | 2005-08-12 | 2011-04-06 | 花王株式会社 | Transparent gel detergent composition |
JP4692358B2 (en) | 2006-03-31 | 2011-06-01 | 日油株式会社 | Hot cleansing fee |
JP4953695B2 (en) * | 2006-06-08 | 2012-06-13 | 株式会社 資生堂 | Transparent liquid cleaning material |
JP5153352B2 (en) * | 2008-01-18 | 2013-02-27 | 小林製薬株式会社 | Cleansing cosmetic composition |
-
2011
- 2011-09-16 JP JP2012535019A patent/JP5861639B2/en active Active
- 2011-09-16 WO PCT/JP2011/071189 patent/WO2012039350A1/en active Application Filing
- 2011-09-16 KR KR1020137006662A patent/KR101790822B1/en active IP Right Grant
- 2011-09-21 TW TW100133957A patent/TWI515013B/en active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01151510A (en) * | 1987-12-09 | 1989-06-14 | Lion Corp | Detergent composition |
JPH0762389A (en) * | 1993-06-18 | 1995-03-07 | Shiseido Co Ltd | Detergent composition |
JPH09279192A (en) * | 1996-04-09 | 1997-10-28 | Nof Corp | Transparent gel-like cleansing agent composition |
JP2005008682A (en) * | 2003-06-17 | 2005-01-13 | Pola Chem Ind Inc | Cream-like detergent |
JP2007211232A (en) * | 2005-10-31 | 2007-08-23 | Kao Corp | Thickening/foam boosting agent |
JP2007169248A (en) * | 2005-12-26 | 2007-07-05 | Lion Corp | Liquid skin cleanser composition |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021078412A1 (en) * | 2019-10-21 | 2021-04-29 | Jallal Messadek | Fractal formulations |
Also Published As
Publication number | Publication date |
---|---|
KR20130110157A (en) | 2013-10-08 |
TW201302226A (en) | 2013-01-16 |
TWI515013B (en) | 2016-01-01 |
KR101790822B1 (en) | 2017-11-20 |
JPWO2012039350A1 (en) | 2014-02-03 |
JP5861639B2 (en) | 2016-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2644185B1 (en) | Thick cleaning composition | |
JP4976184B2 (en) | Liquid detergent composition | |
JP5591436B2 (en) | Low temperature stable cream detergent composition | |
BR112015013023B1 (en) | skin cleansing composition | |
WO2014171238A1 (en) | Cleansing composition for pump foamer | |
JP5838816B2 (en) | Liquid skin cleanser products | |
JP6240085B2 (en) | Cleaning composition | |
JP5623723B2 (en) | Skin cleanser | |
JP5861639B2 (en) | Skin cleanser composition | |
EP1411892B1 (en) | Aqueous narceous concentrate compositions comprising ethoxylated glycerides | |
JP5125333B2 (en) | Gelling agent, gel-like composition and use thereof | |
CN108348430B (en) | Cleaning agent composition for pump bubbler | |
JP2015172041A (en) | detergent composition | |
JP6555595B2 (en) | Method for reducing critical micelle concentration | |
WO2013141118A1 (en) | Liquid detergent composition | |
JP2016113510A (en) | Thixotropy-imparting agent | |
JP2009057515A (en) | Gelling agent, gel-like composition, and its use | |
JP5691292B2 (en) | Skin cleanser composition | |
JP7039967B2 (en) | Acyl amino acid high compound composition | |
JP2017066048A (en) | Creamy detergent compositions and production methods thereof | |
JP6645817B2 (en) | Pearlescent brightener | |
JP2024037116A (en) | Cleansing cosmetic | |
JP2019001847A (en) | Detergent composition | |
JP2010043231A (en) | Gelling agent and gel composition | |
WO2018101370A1 (en) | Acyl amino acid-rich composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11826795 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2012535019 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20137006662 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11826795 Country of ref document: EP Kind code of ref document: A1 |